Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.23.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 504,581 $ 2,066,793
Investment in debt securities 978,479 2,120,082
Accounts receivable, net of allowance for doubtful accounts of $2,716 and $0, respectively 983,635 766,692
Prepaid expenses and other 383,151 329,351
Inventory 146,072 151,248
Total Current Assets 2,995,918 5,434,166
Fixed assets, net of accumulated depreciation of $1,407,767 and $1,134,680, respectively 4,254,235 4,589,159
Operating lease right of use asset 466,744 521,782
Other assets 53,016 52,737
Total Assets 7,769,913 10,597,844
Current Liabilities:    
Accounts payable and accrued liabilities 823,641 1,256,479
Borrowings under revolving line of credit 1,000,000 1,000,000
Loans payable - current 769,754 811,516
Operating lease liabilitie - current 233,738 230,014
Total Current Liabilities 2,827,133 3,298,009
Loans payable, net of current portion 1,015,754 1,198,380
Operating lease liabilities, net of current portion 267,227 316,008
Total Liabilities 4,110,114 4,812,397
Commitments and Contingencies
Stockholders’ Equity (Deficit)    
Preferred stock, $.0001 par value; 5,000,000 shares authorized; 0 shares issued and outstanding
Common stock, $.0001 par value; 50,000,000 shares authorized; 3,350,577 and 3,335,674 shares issued and outstanding at March 31, 2023, and December 31, 2022, respectively 335 334
Additional paid in capital 40,866,924 40,674,864
Accumulated deficit (37,193,932) (34,845,161)
Accumulated other comprehensive loss (13,528) (44,590)
Total Stockholders’ Equity 3,659,799 5,785,447
Total Liabilities and Stockholders’ Equity $ 7,769,913 $ 10,597,844